Literature DB >> 28327844

[Clinical practice guidelines in Peru: evaluation of its quality using the AGREE II instrument].

Carlos Canelo-Aybar1,2, Graciela Balbin1,3, Ángela Perez-Gomez4, Iván D Florez5,6.   

Abstract

To evaluate the methodological quality of clinical practice guidelines (CPGs) put into practice by the Peruvian Ministry of Health (MINSA), 17 CPGs from the ministry, published between 2009 and 2014, were independently evaluated by three methodologic experts using the AGREE II instrument. The score of AGREE II domains was low and very low in all CPGs: scope and purpose (medium, 44%), clarity of presentation (medium, 47%), participation of decision-makers (medium, 8%), methodological rigor (medium, 5%), applicability (medium, 5%), and editorial independence (medium, 8%). In conclusion, the methodological quality of CPGs implemented by the MINSA is low. Consequently, its use could not be recommended. The implementation of the methodology for the development of CPGs described in the recentlypublished CPG methodological preparation manual in Peru is a pressing need.

Mesh:

Year:  2016        PMID: 28327844     DOI: 10.17843/rpmesp.2016.334.2559

Source DB:  PubMed          Journal:  Rev Peru Med Exp Salud Publica        ISSN: 1726-4634


  2 in total

1.  Extending the RIGHT statement for reporting adapted practice guidelines in healthcare: the RIGHT-Ad@pt Checklist protocol.

Authors:  Yang Song; Andrea Darzi; Monica Ballesteros; Laura Martínez García; Pablo Alonso-Coello; Thurayya Arayssi; Soumyadeep Bhaumik; Yaolong Chen; Francoise Cluzeau; Davina Ghersi; Paulina F Padilla; Etienne V Langlois; Holger J Schünemann; Robin W M Vernooij; Elie A Akl
Journal:  BMJ Open       Date:  2019-09-24       Impact factor: 2.692

2.  Factors Associated with the Quality and Transparency of National Guidelines: A Mixed-Methods Study.

Authors:  Tanja Kovačević; Davorka Vrdoljak; Slavica Jurić Petričević; Ivan Buljan; Dario Sambunjak; Željko Krznarić; Ana Marušić; Ana Jerončić
Journal:  Int J Environ Res Public Health       Date:  2022-08-03       Impact factor: 4.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.